Back to Search
Start Over
Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
- Source :
- Stem Cell Research & Therapy, Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
- Publication Year :
- 2021
- Publisher :
- BioMed Central, 2021.
-
Abstract
- Background Mesenchymal stem cells (MSCs) exert positive effects in chronic wounds. However, critical parameters, such as the most effective administration routes, remain unclear. Accordingly, the purpose of this study was to compare the effects of topical and systemic transplantation MSCs on diabetic ischemic wound healing and explored the underlying mechanisms. Method A diabetic ischemic wound model was created on the dorsal foot of type 2 diabetes mellitus (T2DM) rat. Bone marrow-derived mesenchymal stem cells (BM-MSCs) were administered via two routes: topical injection and intravenous (IV) infusion. Wound healing outcomes and blood glucose level were assessed dynamically. Meanwhile, blood flow recovery was evaluated in ischemic gastrocnemius muscles. The homing and transdifferentiation of mKate2-labeled BM-MSCs were assessed by fluorescence imaging and immunohistochemistry (IHC) analysis. Result Both topical and systemic treatments had a positive effect on the diabetic ischemic wound showing a significant reduction in wound area at day 14. Histological results showed an increase in the length of epithelial edges, collagen content, microvessel density in the wound bed, and a higher expression of vascular endothelial growth factor (VEGF). Meanwhile, systemic administration can ameliorate hyperglycemia and improve the blood perfusion of the ischemic hindlimb. BM-MSCs administered systemically were found distributed in wounded tissue and transdifferentiated into endothelial cells. Furthermore, BM-MSCs stimulated angiogenesis at wound sites by downregulating phosphatase and tensin homolog (PTEN) and activation of AKT signaling pathway. Conclusions The results demonstrated that both transplantation delivery method (topical and systemic) of BM-MSCs accelerated wound healing remarkably under pathological conditions. Nevertheless, systemic administration has the potential to ameliorate hyperglycemia and repair the damaged tissue.
- Subjects :
- Vascular Endothelial Growth Factor A
Angiogenesis
Medicine (miscellaneous)
Pharmacology
Mesenchymal Stem Cell Transplantation
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Bone marrow-derived mesenchymal stem cells
lcsh:Biochemistry
chemistry.chemical_compound
Type 2 diabetes mellitus
Medicine
Animals
lcsh:QD415-436
Chronic wounds
lcsh:R5-920
Wound Healing
business.industry
Research
Mesenchymal stem cell
Transdifferentiation
Critical limb ischemia
Endothelial Cells
Mesenchymal Stem Cells
Cell Biology
Rats
Vascular endothelial growth factor
Transplantation
chemistry
Diabetes Mellitus, Type 2
Systemic administration
Diabetic foot ulcers
Molecular Medicine
Stem cell
lcsh:Medicine (General)
Wound healing
business
Subjects
Details
- Language :
- English
- ISSN :
- 17576512
- Volume :
- 12
- Database :
- OpenAIRE
- Journal :
- Stem Cell Research & Therapy
- Accession number :
- edsair.doi.dedup.....7e4ac17458a0e2719220614c9448281b